Endologix Inc (ELGX) 14.24 $ELGX Upgrade Alert for

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2016 at 9:16 AM

Endologix Inc (ELGX) 14.24 $ELGX

Upgrade Alert for Endologix (ELGX)
Comtex SmarTrend(R) - Fri Jul 08, 3:01AM CDT
Endologix (NASDAQ:ELGX) was upgraded from Market Perform to Outperform at BMO Capital today. The stock closed yesterday at $13.70 on volume of 2.1 million shares, above average daily volume of 866,000. Over the past year, Endologix has traded in a range of $6.51 to $18.07 and closed yesterday at $13.70, 110% above that low. Over the last five market days, the 200-day moving average (MA) has gone down 0.6% while the 50-day MA has advanced 3.2%.
ELGX: 14.24 (+0.54)

Uptrend Call Working As Endologix Stock Rises 46.1% (ELGX)
Comtex SmarTrend(R) - Wed Jul 06, 12:36AM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 4 months, Endologix has returned 46.13% as of today's recent price of $12.83.
ELGX: 14.24 (+0.54)

Endologix Reports Positive Clinical Data on the Nellix EVAS System from a Multicenter Study in Italy
GlobeNewswire - Thu Jun 09, 8:33AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today positive clinical data from the Italian Research Nellix Endoprosthesis ("IRENE"

study at the 2016 Society of Vascular Surgery ("SVS"

Annual Meeting. This retrospective, multicenter study was designed to evaluate the Nellix(R) EndoVascular Aneurysm Sealing System ("Nellix EVAS System"

for the endovascular repair of infrarenal abdominal aortic aneurysms ("AAA"

.
ELGX: 14.24 (+0.54)

Medical Instruments & Supplies Equities Roundup -- Endologix, Becton Dickinson, Waters, and OraSure Technologies
PR Newswire - Thu Jun 09, 7:25AM CDT
On Wednesday, June 08, 2016, the NASDAQ Composite ended the trading session at 4,974.64, up 0.26%; the Dow Jones Industrial Average advanced 0.37% to finish at 18,005.05; and the S&P 500 closed at 2,119.12, up 0.33%. The gains were broad based as all the sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Company (NYSE: BDX), Waters Corporation (NYSE: WAT), and OraSure Technologies Inc. (NASDAQ: OSUR). Learn more about these stocks by accessing their free trade alerts at:
BDX: 175.64 (+2.47), ELGX: 14.24 (+0.54), WAT: 146.53 (+4.06), OSUR: 6.44 (+0.24)

Endologix Up 45.6% Since SmarTrend Uptrend Call (ELGX)
Comtex SmarTrend(R) - Fri Jun 03, 12:48PM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 3 months, Endologix has returned 45.56% as of today's recent price of $12.78.
ELGX: 14.24 (+0.54)

Endologix to Present at Jefferies Healthcare Conference
GlobeNewswire - Fri Jun 03, 8:00AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today it will present at the Jefferies Healthcare Conference in New York, NY.
ELGX: 14.24 (+0.54)

Endologix Has Returned 45.0% Since SmarTrend Recommendation (ELGX)
Comtex SmarTrend(R) - Fri May 27, 12:32AM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 3 months, Endologix has returned 44.99% as of today's recent price of $12.73.
ELGX: 14.24 (+0.54)

After Yesterday's Rally of 3.49% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu May 26, 3:21PM CDT
Endologix (NASDAQ:ELGX) traded in a range yesterday that spanned from a low of $12.33 to a high of $12.93. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $12.59 on volume of 979,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ELGX: 14.24 (+0.54)

Endologix Reports Positive Clinical Data from the Nellix EVAS FORWARD-IDE Study
GlobeNewswire - Thu May 26, 8:00AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today positive clinical data from the Nellix investigational device exemption (IDE) clinical trial, the EVAS FORWARD-IDE Study (www.clinicaltrials.gov, NCT01726257). This multicenter, prospective, single arm clinical study is designed to evaluate the safety and effectiveness of the Nellix(R) EndoVascular Aneurysm Sealing System ("Nellix EVAS System"

for the endovascular repair of infrarenal abdominal aortic aneurysms ("AAA"

. The data from the EVAS FORWARD-IDE study demonstrated that the Nellix EVAS System met the study primary endpoints for major adverse events at 30 days (safety) and Treatment Success at one year (effectiveness).
ELGX: 14.24 (+0.54)

36.2% Return Seen to Date on SmarTrend Endologix Call (ELGX)
Comtex SmarTrend(R) - Thu May 19, 1:01PM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 3 months, Endologix has returned 36.22% as of today's recent price of $11.96.
ELGX: 14.24 (+0.54)

Endologix Completes Patient Enrollment in the Ovation(R) LIFE (Least Invasive Fast-Track EVAR) Study
GlobeNewswire - Mon May 16, 8:00AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient enrollment in the LIFE study, a multi-center post-market registry designed to evaluate the Ovation Abdominal Stent Graft Platform when used in the treatment of patients with abdominal aortic aneurysms ("AAA"

using a Fast-Track EVAR protocol. The LIFE study is the first of its kind using a Fast-Track EVAR protocol, which includes bi-lateral percutaneous access enabled by the Ovation Platform ultra-low profile (14F) design, avoidance of general anesthesia and intensive care unit ("ICU"

admission post procedure, and next-day discharge.
ELGX: 14.24 (+0.54)

Endologix Reports Results for the First Quarter 2016
GlobeNewswire - Mon May 09, 3:07PM CDT
Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three months ended March 31, 2016.
ELGX: 14.24 (+0.54)

Shares of ELGX Up 24.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed May 04, 1:25PM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 2 months, Endologix has returned 24.26% as of today's recent price of $10.91.
ELGX: 14.24 (+0.54)

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Endologix, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
PR Newswire - Wed May 04, 10:19AM CDT
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Endologix, Inc. (NASDAQ:ELGX).
ELGX: 14.24 (+0.54)

Endologix to Participate in Two Investor Conferences in May
GlobeNewswire - Fri Apr 29, 8:00AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chief Executive Officer, and Vaseem Mahboob, Chief Financial Officer, are scheduled to participate at two investor conferences in May. The first conference is the Deutsche Bank 41 Annual Health Care Conference in Boston, Massachusetts.
DB: 13.20 (+0.23), ELGX: 14.24 (+0.54)

Positive Nellix Clinical Data from the ASCEND Study for the Treatment of Juxta and Pararenal AAA Presented at the 38th Annual Charing Cross Symposium
GlobeNewswire - Thu Apr 28, 11:15AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the first data presentation from the ASCEND Registry (Aneurysm Study for Complex AAA: Evaluation of Nellix Durability), a physician-initiated registry of the Nellix EndoVascular Aneurysm Sealing System ("Nellix EVAS System"

used with aortic branch stent grafts for the treatment of patients with complex abdominal aortic aneurysms ("AAAs"

. Professor Matthew Thompson, MD, Professor of Vascular Surgery, St. Georges Vascular Institute, London, and one of the principal investigators of the ASCEND Registry, presented the results at the 38th Annual Charing Cross Symposium being held April 26-29 in London, UK. The Nellix EVAS System is approved for investigational use only in the U.S.
ELGX: 14.24 (+0.54)

Endologix to Report First Quarter 2016 Financial Results on May 9, 2016
GlobeNewswire - Tue Apr 19, 3:00PM CDT
Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today details relating to the release of its first quarter 2016 financial results, which will take place on Monday, May 9, 2016 after the close of the market.
ELGX: 14.24 (+0.54)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duke Energy's Cost-Protection Plan Shields Ratepayers

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Wally Disrupts Dental Industry with $25M Funding

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Decoding CarBravo-Certified vs Traditional Used Cars

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Merit Expands in New York with Bold Acquisition Move

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Ornellaia's 2026 Harvest: Adapting to Nature's Whims

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

C3EL Expands Federal Footprint with Strategic Contracts

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Gong, Agentforce, Avoma Crowned 2026 CI Champions

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

EMCO's New Automated Facility Could Shake Industry

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...